iveda solutions inc shares were down 42 to 330 after the company said it priced its underwritten public offering of 19 million common shares and accompanying warrants to buy 19 million shares at 425 a share and accompanying warrant the warrants will be immediately exercisable at a price of 425 a share of stock and will expire five years from the date of issuance the shares and the accompanying warrants can only be purchased together in the offering but will be issued separately and will be immediately separable upon issuance iveda expects to receive proceeds of 8 million before deducting underwriting discounts and commissions and other estimated offering expenses in connection with the offering and to qualify for nasdaq listing the company effectuated a reverse split of its issued and outstanding common stock at a ratio of 1for8 effective thursday after trading closed iveda has granted the underwriters a 45day option to purchase up to an additional 280000 shares andor up to an additional 280000 warrants at the public offering price to cover overallotments if any the offering is expected to close tuesday